PT-141 serves as a cutting-edge cyclic melanocortin agonist that possesses potential in the treatment of sexual dysfunction. This novel compound acts by activating specific receptors throughout the body, causing to augmented sexual response. Preclinical studies have indicated that PT-141 could effectively manage a variety of sexual dysfunctions in